International Patent: CRISPR/CAS9-MEDIATED EXON 13 SKIPPING APPROACHES FOR USH2A-ASSOCIATED USHER SYNDROME

GENEVA, Aug. 21 -- MASSACHUSETTS EYE AND EAR INFIRMARY filed a patent application (US2026/015108) for “CRISPR/CAS9-MEDIATED EXON 13 SKIPPING APPROACHES FOR USH2A-ASSOCIATED USHER SYNDROME”. With publication no. WO/2026/174098, here are the other details related to the patent application:

Kind: Initial Publication without ISR [A2]

IPC: C12N 9/22

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....